// SCAD - stable coronary artery disease

digraph SCAD {
	ranksep=0.1;
node [shape=box, style=filled, fillcolor=green, fontname=Calibri, fontsize=11];
edge [fontname="Calibri Italic", fontsize=10];

// Context
c_scad [label="Patient diagnosed \n with SCAD [SCAD]", shape=oval, style=filled, fillcolor=red];

event_risk [shape=diamond, fillcolor=yellow, label="Event risk?"];
parallel_1 [shape=circle, label="", width=0.2, fillcolor=black];
parallel_2 [shape=circle, label="", width=0.2, fillcolor=black];
parallel_3 [shape=circle, label="", width=0.2, fillcolor=black];
parallel_4 [shape=circle, label="", width=0.2, fillcolor=black];
line_1_1 [label="1st line: \n Short-acting nitrates + \n [beta-blockers (BB) or calcium channel blockers (CCB)]"];
line_2_1 [label="2nd line: \n Long-lasting nitrates + \n [ivabradine or nicorandil or ranolazine or trimetazidine]"];
line_1_2 [label="1st line (continued)..."];
line_2_2 [label="2nd line (continued)..."];
symptoms_improved_1 [shape=diamond, fillcolor=yellow, label="Symptoms improved?"];
symptoms_improved_2 [shape=diamond, fillcolor=yellow, label="Symptoms improved?"];

event_prevention_1 [label="Event prevention 1: \n Lifestyle management; \n Control of risk factors"];
event_prevention_2 [label="Event prevention 2: \n Aspirin + statins"];

stenosis [shape=diamond, fillcolor=yellow, label="Stenosis?"];
pharmacotherapy [shape=diamond, fillcolor=yellow, label="Pharamcotherapy\n preferred?"];

ica_ffr [label="Diagnostic invasive coronary angiography (ICA); \n Fractional flow reserve (FFR)"];
revascularization [label="Revascularization"];
nitrates [label="Short-acting nitrates"];
renal_complications [shape=diamond, fillcolor=yellow, label="Renal\n complications?"];
acei [label="ACE inhibitor (ACEI)"];

// Event nodes
e_start [shape=circle, label="", width=0.3, penwidth=2, fillcolor="gray"];
e_end [shape=circle, label="", width=0.3, penwidth=6, fillcolor="gray"];

e_start -> c_scad -> event_risk;
event_risk -> parallel_1 [label = low];
parallel_1 -> line_1_1;
parallel_1 -> event_prevention_1;
line_1_1 -> parallel_2;
event_prevention_1 -> parallel_2;
parallel_2 -> symptoms_improved_1;
symptoms_improved_1 -> line_1_2 [label=yes];
symptoms_improved_1 -> parallel_3 [label=no];
parallel_3 -> line_2_1;
parallel_3 -> event_prevention_2;
line_2_1 -> parallel_4;
event_prevention_2 -> parallel_4;
parallel_4 -> symptoms_improved_2;
symptoms_improved_2 -> line_2_2 [label=yes];

event_risk -> stenosis [label=intermediate];
stenosis -> pharmacotherapy [label=no];
pharmacotherapy -> parallel_1 [label=yes];

event_risk -> ica_ffr [label=high];
ica_ffr -> revascularization;
stenosis -> revascularization [label=yes];
pharmacotherapy  -> revascularization [label=no];
symptoms_improved_2 -> revascularization [label=no];
revascularization -> nitrates;
nitrates -> renal_complications;
renal_complications -> line_2_2 [label=no];
renal_complications -> acei [label=yes];
acei -> line_2_2 -> e_end;
}
